Kestrel Therapeutics Inc.
Boston, MA · Founded 2020 · CIK 0001853373 · Biotech · Private
Targeted cancer therapeutic molecules
kestreltherapeutics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $21M
- 4 Form D · Aug 2025
- 14 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 16
- 0 granted · 16 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $228,000 | |
| Private capital raised | Form D · SEC | $7,500,000 | |
| Private capital raised | Form D · SEC | $8,000,000 | |
| Private capital raised | Form D · SEC | $5,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2470 | Rocket Pharmaceuticals Ltd. | — | $28M |
| 2471 | BIOSTRATEGIES LC | — | — |
| 2472 | Fulgent Pharma LLC | — | $5.4M |
| 2473 | Kestrel Therapeutics Inc. | — | $21M |
| 2474 | FIBRONOX, L.L.C. | — | — |
| 2475 | Aulos Bioscience, Inc. | — | $20M |
| 2476 | Surf Bio, Inc. | — | $16M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Frank HaluskaDirector · Executive Officer
- Omar KhalilDirector
- Denis PatrickDirector
- Andrew PhillipsDirector
- Nicholas SaccomanoDirector
- Barbara SosnowskiDirector
Patents
- Ras Inhibitors And Methods Of Use Thereofapplication
- Ras Inhibitors And Methods Of Use Thereofapplication
- Ras Inhibitors And Methods Of Use Thereofapplication
- Ras Inhibitors And Methods Of Use Thereofapplication
- Ras Inhibitors And Methods Of Use Thereofapplication
- Ras Inhibitors And Methods Of Use Thereofapplication
- Ras Inhibitors And Methods Of Use Thereofapplication
- Ras Inhibitors And Methods Of Use Thereofapplication
- Ras Inhibitors And Methods Of Use Thereofapplication
- Ras Inhibitors And Methods Of Use Thereofapplication
- Ras Inhibitors And Methods Of Use Thereofapplication
- Ras Inhibitors And Methods Of Use Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.